BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
171 – 180 of 3085
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The Biology of the Nuclear Envelope and Its Implications in Cancer Biology
- Contribution to journal › Scientific review
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
- Contribution to journal › Article
-
Mark
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia : A Retrospective Multinational Study
- Contribution to journal › Article
-
Mark
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis
(2019) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28(5). p.935-942
- Contribution to journal › Article
-
Mark
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study
(2019) In European Radiology Experimental
- Contribution to journal › Article
-
Mark
Incidental metastases and lymphoma of the gallbladder–an analysis of ten rare cases identified from a large national database
- Contribution to journal › Article
-
Mark
Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations : effect of a prospective intervention in primary bladder cancer patients
- Contribution to journal › Article
-
Mark
Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging-a comprehensive overview
- Contribution to journal › Scientific review
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
- Contribution to journal › Article
